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Introduction 
Tea and Cancer 
 Tea is one of the most consumed beverages on Earth, second only to water. In 2010, over 
3 billion gallons of tea were consumed by Americans, with black tea and black tea accounting 
for 80% and 19.5%, respectively (1). Tea consumption has been associated with a positive effect 
on certain diseases, including arthritis, HIV, and cancers of the gastrointestinal (GI) tract (2,3). 
In many populations, including Japanese women, the risk of gastric cancer decreases with 
increased consumption of tea (4). Green tea has also been shown to reduce inflammation of the 
gastric epithelium, which is a significant risk factor for gastric cancer(5). Of the many 
compounds found in green tea, the catechins, a group of polyphenols, are considered to be the 
primary bioactive components (Fig. 1). 
 There have been many studies on the effects of catechins on the human body, especially 
epigallocatechin gallate (EGCG), one of the abundant catechins in green tea. EGCG has many 
effects in the GI tract, such as inhibiting NF-κB activity (6). NF-κB is a protein that is 
responsible for many inflammatory pathways, and thus the inhibitory effects of tea catechins 
may be the basis by which gastric cancers are prevented by green tea. Green tea has also been 
associated with the inhibition of cancer cell proliferation in the stomach, which is often attributed 
to its antioxidant activity (7). Whether this is the sole pathway is controversial. Furthermore, the 
mechanism by which EGCG and other catechins are taken up by the stomach tissue is still 
unclear. 
 
Cancer Proliferation 
 For a tumor to grow, its cells need to undergo mitosis, and as such they require vast 
amounts of energy and nutrients. Tumors are made up of cells that often differentiate due to their 
access to the blood stream and essential nutrients. These differentiated cell types generally 
integrate their metabolism of nutrients (Fig. 2). Cells that are distal to the vasculature (hypoxic 
cells) will metabolize glucose and efflux lactate. This lactate is taken up by oxidative cancer cells 
by the monocarboxylate trasporter-1 (MCT-1) with preferential metabolism compared to glucose 
(8). Some studies have shown that this metabolic relationship can be disrupted by inhibiting 
MCT-1, which would therefore reduce the proliferation of these tumors (9). 
 
Monocarboxylate Transporters 
 Monocarboxylate transporters (MCT) are a family of proteins that are found in the 
plasma membrane of many cell types. At least 5 MCT isoforms have been isolated, with MCT-1 
being the first discovered and also the most thoroughly characterized. MCT-1 transports small 
monocarboxylates such as lactate, pyruvate, and butyrate into the cell by a proton-dependent 
mechanism. (10) While present on the apical surface of much of the GI tract, it is only expressed 
on the basolateral membrane of the gastric epithelium (11). Of the remaining MCTs, MCT-2 and 
MCT-4 have been the most studied. MCT-2 has a similar function to MCT-1, but has a higher 
affinity for pyruvate and lactate (10). MCT-2 expression is low in normal tissue, but can be 
elevated in cancer tissue (10). Like MCT-1, MCT-4 is responsible for the efflux of 
monocarboxylates from the cell. Some, but not all, studies have suggested that MCT may play a 
role in catechin uptake into the small intestine (12, 13). MCT is also being studied as a potential 
method to disrupt the metabolism of tumor cells (14). 
 
BCECF Assay 
 Developed by Halestrap, the BCECF assay uses the intracellular, pH-dependent, 
fluorescent dye 2',7' -bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) to indirectly 
measure lactate uptake into the cell. Cells are exposed to the acetylmethylated ester  BCECF 
(BCECF-AM). The hydrophobic ester diffuses across the cell membrane and is de-esterified in 
the cytosol by endogenous esterase activity. Once de-esterified, the anionic form undergoes 
structural changes based on the internal pH of the cell, with each form fluorescing at different 
intensities. Cells are then exposed to lactate and pH is determined by fluorimetry. One can also 
treat the cells with inhibitors of MCT to assess inhibition of lactate uptake. This assay has 
primarily been done with suspended cell types such as Ehrliche-Ascites tumor cells, whereas 
data with adherent cell types is minimal (15). 
 
Phytochemicals and the Stomach 
 The stomach, compared to the intestines and even the oral cavity, is rarely thought of as 
an organ that absorbs nutrients. This is a rather narrow-minded view, as it is known that alcohol 
and other drugs are absorbed through the stomach lining (16, 17). In fact, recent evidence from 
mouse models has shown that a group of phytochemicals known as anthocyanins can be 
absorbed through the stomach (18). This raises the question of what other nutrients and 
xenobiotics may be absorbed in the stomach. 
 
The Present Study 
 The objective of my thesis project was to determine the effect of catechins on lactate 
uptake in two human gastric cells lines, i.e., the gastric adenocarcinoma cell line AGS and a 
gastric carcinoma cell line derived from a metastasis in the liver (NCI-N87) (Fig. 3).  The NCI-
N87 cell line is unique in that it develops into a highly differentiated monolayer that displays an 
exemplary epithelial phenotype, including characteristics such as mucin production and 
expression of enzymes such as gastric lipase (19). In order to determine a pathway through 
which cancer proliferation is inhibited by tea, catechins have been used to determine their 
inhibitory effects on lactate uptake compared to phloretin, a known inhibitor of MCT. This will 
be done in a variation of Halestrap’s BCECF assay, which has been adapted for use with 
adherent cell lines. 
  
  
  
Figure 1: The Catechins. 
Catechin (C), Epicatechin (EC), Epigallocatechin (EGC), Epicatechin galltate (ECG), and 
Epigallocatechin gallate (EGCG). 
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Figure 2: Tumor Metabolism. In tumors, cells express hypoxic and oxidative phenotypes, that 
work together to metabolize glucose and its products. This relationship is largely dependent on 
MCTs. Based on Semenza et al (2008). 
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Materials and Methods 
I- Materials 
BCECF-AM was purchased from Invitrogen. EGCG, phloretin, albumin, and 
lactate were purchased from Sigma Aldrich. All cell culture equipment was purchased 
from Fisher Scientific. All experiments were performed in Falcon 48-well plates. 
Assay buffer for the BCECF assay was prepared as previously described by 
Halestrap et al (15). Final concentrations were as follow: 150 mM Na
+
, 5 mM K
+
, 150 
mM Cl
-
, 1 mM Ca
2+
, 1 mM sulfate, 1 mM phosphate, 3.3 mM Mops, 3.3 mM Tris, and 5 
mM HEPES, adjusted to pH 7.4 at 25 °C.  
 
II- Cell Culture  
AGS cells and NCI-N87 cells were purchased from ATCC. AGS cells were 
grown in DMEM with 10% FBS, 1% Penicillin/Streptomycin, and 2 mM L-glutamine. 
NCI-N87 cells were grown in RPMI 1640 with 10% FBS and 1% Penicillin/ 
Streptomycin). All cultures were maintained in an atmosphere of 95% air: 5% CO2 at 
37°C. Cultures were split when cells were 90 % confluent by exposing the cells to 0.25% 
trypsin-EDTA. Cell concentration was determined with a hemocytometer. 48-well plates 
were seeded at a density of 2.0 x 10
5
 cells per mL. Passages 5-21 were used for the 
subsequent studies. AGS wells were used once confluency was reached. NCI-N87 wells 
were used 18 days-post confluency. 
 
III- BCECF concentration titration 
In order to determine the appropriate concentration of BCECF, cells were exposed 
to various concentrations of BCECF and then read in a fluorometer. Confluent cultures 
were treated with 4 µM, 10 µM, and 40 µM BCECF or blank without media for 30 
minutes at room temperature. Fluorescence was determined using an excitation 
wavelength of 530 nm and an emission wavelength of 590 nm. 
 
IV- MTT Assays for phloretin 
To examine the cytotoxic effects of these phytochemicals, an MTT assay was 
performed. Briefly, media was removed from confluent cultures and the cells were 
incubated in medium containing phloretin (0 µM, 3.13 µM, 6.25 µM, 12.5 µM, 25 µM, 
50 µm, and 100 µM) and incubated at 37°. After 48 hours, medium was removed and the 
cells were incubated with medium containing yellow tetrazolium MTT ((3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 15 µL, 5 mg/mL) for 3 hours. 
The MTT is reduced by mitochondrial dehydrogenase enzymes, resulting in a purple 
precipitate. Medium was aspirated and the monolayer was washed with phosphate-
buffered saline. This precipitate was dissolved in 150 µL 0.04N HCl-isopropanol, and the 
absorbance was read at 610 nM. 
 
V- Lactate Titration 
Three concentrations of lactate were tested in order to determine the concentration 
needed for appropriate intensity of the signal in the BCECF assay. Confluent cultures 
were incubated at 6° C for 20 minutes before spent medium was removed.500 µL 
BCECF (10 µM) in assay buffer was added to each well, and cultures were incubated at 
room temperature for 30 minutes. Buffer was removed and the cells were then washed 
once with assay buffer, twice with albumin (2 g/L) in assay buffer, and then again with 
assay buffer. The cells were then exposed with 500 µL of lactate (2 mM, 10 mM, 25 
mM) in assay buffer. Dishes were immediately placed in a fluorometer and analyzed at 
an excitation wavelength of 530 nm and an emission wavelength of 590 nm for 20 
minutes. 
 
VI- Lactate Uptake and Inhibition by EGCG 
In order to measure lactate uptake and its inhibition by EGCG, a modified version 
of the BCECF Assay described by Halestrap was used. Phloretin, a known inhibitor of 
MCT, was used as a positive control. AGS cells were then incubated at 6°C for 20 
minutes. After incubation, spent media was withdrawn and the cells were treated with 
500 µL BCECF (10 µM) in assay buffer, except for BCECF- control wells, which 
received assay buffer only for the rest of the procedure. The treated cells were left at 
room temperature for 30 minutes. The cells were then washed once with assay buffer, 
twice with albumin (2 g/L), and then again with assay buffer. Following the wash, control 
wells were pretreated with 500 µL phloretin (200 µM) in assay buffer, EGCG (200 µM) 
in assay buffer, or assay buffer for 2 minutes. The wells were then placed on ice and 
incubated with 500 µL assay buffer. Treatment wells were pretreated with 500 µL 
phloretin (200 µM) in assay buffer, EGCG (200 µM) in assay buffer, or assay buffer for 2 
minutes after the wash, and then exposed with 500 µL lactate (10 mM) in assay buffer. 
Immediately following treatment with lactate or assay buffer, the fluorescence was 
measured at an excitation of 530 nm and emission of 590 nm for 15 minutes.  
The process above was identical for NCI-N87. 
 
VII- BCECF Assay with Various Catechins 
In order to test the effect of other tea catechins on lactate uptake, the the BCECF 
assay was repeated using EGCG (200 µM), epigallocatechin (EGC, 200 µM), epicatechin 
gallate (ECG, 200 µM), epicatechin (EC, 200 µM), and catechin (C, 200 µM). The cells 
were treated and fluorescence was measured as above. 
 
VIII- Statistics 
Statistical significance was calculated using Student’s t-test. Results with p<0.05 
were deemed statistically significant. For BCECF and lactate concentration experiments, 
n=4. For MTT and BCECF assays, n=6. 
  
Results 
I- BCECF Concentration 
 With increasing concentrations of BCECF in the assay buffer, cellular fluorescence 
increased. The ratio of change in concentration over change in fluorescence for 4 µM to 10µM 
was 23 fluorescence units/µM compared to 12 fluorescence units/µM for 10 µM to 40 µM. (Fig. 
4) Thus, 10 µM was chosen as the concentration to be used in subsequent experiments.  
 
II- MTT Assay for Phloretin 
 As concentration of phloretin increases, the percentage of absorbance, and therefore 
viable cells. Exposure of cells to as high as 25 µM phloretin did not significantly reduce 
respiratory activity. However, respiratory activity was significantly decreased following 
incubation in medium containing 50 µM and 100 µM phloretin, with declines of 18% and 52%, 
respectively (Fig. 5). Observation of cells after MTT assay revealed that cells were still viable up 
to 100 µM. 
 
III- Lactate Titration 
BCECF fluorescence, and thus intracellular pH, was altered during exposure to assay 
buffer containing 2-25 mM lactate. The response was dose-dependent with the most marked 
change observed during the initial 10 minutes of incubation. (Fig. 6) 
 
IV- Lactate Uptake and Inhibition with EGCG 
In the AGS cell line, exposure of cultures to assay buffer containing EGCG and phloretin 
significantly inhibited lactate uptake, as decrease in fluorescence was attenuated compared to 
cultures incubated with lactate only (Fig 7). The response of EGCG-treated cells was slightly 
less than that in cultures treated with equivalent phloretin, but still far greater than that of lactate 
alone. The difference in extent of inhibition of lactate uptake was intensified in the NCI-N87 
cells (Fig. 8). 
 
V- BCECF Assay with Various Catechins 
The response of cells to the presence of catechins was dependent on structure, with each 
catechin showed a varying degree of inhibitory effect. Catechin (C) had the greatest inhibitory 
effect on lactate uptake as fluorescence decreased by 16% compared to 31% with the negative 
control upon exposure to lactate (Fig. 9). EGCG also significantly decreased lactate uptake 
compared to the control. In contrast, EC, ECG, and EGC failed to significantly affect lactate 
uptake.  
  
  
Figure 3. The cell lines used in this study were the AGS 
(top) and NCI-N87 (bottom). 
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Figure 4: BCECF Titration in AGS cell line. Bars with different letters are 
considered statistically significant with a p-value <0.05.  
 
  
 
 
Figure 5: MTT Assay in AGS cell line. Bars with different letters are considered 
statistically significant with a p-value <0.05 . 
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Figure 6: Lactate Titration in AGS cell line. Points with different letters are 
considered statistically significant with a p-value <0.05. 
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Figure 7: EGCG, like phloretin, inhibits the reduction in intracellular pH in AGS 
cells. 
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Figure 9: Differential effects of catechins on lactate uptake in AGS cells. 
Points with different letters are considered statistically significant with a p-
value <0.05. 
Discussion 
 The first step of this study was to adapt the BCECF assay developed by Halestrap for 
investigating lactate uptake to be used in adherent cell lines. The original protocol for this assay 
involved the cells being constantly read while continuously spinning in a cuvette. The cell lines 
used in this study were grown on 48-well dishes. In order to account for any background 
fluorescence, all readings were corrected by subtracting the fluorescence emitted by cells without 
BCECF. In fig. 4, various concentrations of BCECF were used to determine the appropriate 
amount for this assay. The concentration of 10 µM was chosen for the level of fluorescent signal, 
the minimal increase at 25 µM, and the cost of the dye. In order to assess the optimal 
concentration of phloretin that could be used as an inhibitor, an MTT assay was performed. 
Although a level of 200 µM was shown to be cytotoxic after 48 hours (fig 5.), this was well 
below the level used in previous Caco-2 models. In addition, as the cells were only exposed to 
phloretin for less than 20 minutes, this concentration was considered to be safe. Concentrations 
of catechins were chosen based on the concentration of phloretin. Lactate was also tested at 
various concentrations, with 25 mM being the initial suggested amount by Dr. Halestrap. More 
dilute solutions were tested, and the 10 mM solution provided a response that was useful over the 
15 minute intervals, although it was not as robust as the 25 mM solution. This was considered so 
that a high concentration of lactate would not saturate MCT and offset the inhibitory effect of the 
catechins. Altogether, these changes to the BCECF assay allowed us to successfully measure 
lactate uptake in our adherent cell lines. 
 The data generated by the BCECF assay support our hypothesis that catechins have an 
inhibitory effect of lactate uptake. The fact that this effect is reproducible in two different cell 
types that are phenotypically distinct also supports this conclusion. Of the two cell types, NCI-
N87 provides the better model for this study, as it has a phenotype that is more characteristic of 
the stomach epithelium, such as forming tight junctions and producing gastric mucin. The 
inhibition of MCT as a mechanism for inhibiting tumor growth is being researched as a possible 
therapeutic method for treating cancer, and this model shows that tea compounds might have a 
similar, though much smaller, effect on gastric tumors.  
 Of the tested catechins, only catechin and EGCG produced a statistically significant 
inhibition of lactate uptake. Epicatechin and epicatechin gallate produced a slight, but 
insignificant, inhibition. Catechin and epitcatechin are both much smaller than the other 
compounds, and they also share a strong structural similarity to phloretin. The structure of these 
three compounds, especially the 5,7, and 4’ hydroxyl groups on the catechins that are parallel to 
the 4, 2’, and 4’ hydroxyl groups on phloretin. The inhibitory effects of EGCG and ECG are 
more surprising, as the addition of the large gallate group make these compounds much larger 
than the other catechins. However, the inhibitory effect of EGCG compared to that of EGC, 
which is only different in that it lacks the gallate group, suggests that the gallate group on these 
compounds might promote the inhibitory effect. 
 Two major concerns are raised when proposing inhibition of lactate uptake mediated by 
MCT-1 as a possible mechanism for the epidemiological data that show that in certain 
populations, gastric cancer rates are decreased with increased consumption of tea. First, many 
reports suggest that MCT-1 is only found on the basolateral surface of the stomach epithelium. 
While there are data supporting this claim, there is also evidence that MCT-1 can also be 
expressed on the apical membrane as well in cancer cells. Also, other phytochemicals, primarily 
anthocyanins, have been shown to be taken up into the gastric epithelium by other proteins such 
as bilitranslocase, and even transported across the basolateral membrane. If this is so for 
catechins, these compounds could be located throughout the stomach tissue. The second issue is 
whether MCT-1 is actually being targeted by phloretin and the catechins and if it is the protein 
facilitating the lactate transfer, to decrease intracellular pH. Further studies are needed to support 
these data. 
 In subsequent studies, this assay will be performed using a synthetic inhibitor with a high 
specificity and inhibitory effect on MCT-1 to determine if MCT-1 is the protein responsible for 
this effect. Further studies are also being done to determine if MCT-1 is involved in the transport 
of catechins into the cell. This can be done with high performance liquid chromatography 
(HPLC) to determine if the amount of catechins and catechin metabolites inside the cell and in 
medium change upon addition of the synthetic inhibitor. This would ideally be done with the 
NCI-N87 line grown on inserts. In this method, the low pH of the stomach can be simulated 
along with the benefits of having a more physiologically relevant phenotype. 
 Monocarboxylate transporters are an exciting class of proteins that could become a novel 
method for the treatment of and prevention of certain kinds of cancers. Tea is one of the most 
commonly consumed beverages around the world, and its bioactive compounds, the catechins, 
have been shown epidemiologically to possess cancer-preventative properties in certain 
populations. These results suggest that catechins have an inhibitory effect on lactate uptake via 
MCTs, which may be one mechanism by which cancer is prevented and its growth inhibited in 
these populations. 
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